Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smecta elemental impurity pharmacokinetics in adults with chronic diarrhea
NL-OMON43250Active, not recruiting
- Sponsor
- Ipsen
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of diosmectite in Chronic diarrhea and functional bowel disorder (FBD), sponsored by Ipsen. Primary endpoint: Blood lead concentration. Started Sep 2016; status: active, not recruiting.
02
Drugs
diosmectite
03
Conditions
Chronic diarrheafunctional bowel disorder (FBD)
Beyond the preview
Go deeper on NL-OMON43250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43250.